stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

EuroEyes International Eye Clinic Limited

Germany · HKEX: 1846.HK · Market cap: · P/E: · P/S:

EuroEyes runs eye clinics that perform laser eye surgery and implant lenses to help people stop wearing glasses and contact lenses.

EuroEyes is a chain of eye clinics that fixes people's eyesight. If you are tired of glasses or contact lenses, you can walk into one of its clinics and pay for a procedure — most often laser surgery that reshapes the surface of your eye so you can see clearly without help. The company also does a lot of lens surgery, where a surgeon removes your natural lens and puts in a new one, which is especially popular with older patients dealing with cataracts or who simply want to throw away their reading glasses.

The clinics sit mostly in Germany, where the company has its roots, plus China, Denmark, the UK, and Switzerland. Patients pay out of their own pocket for most of these procedures, because they are usually treated as elective — a choice to improve your life rather than a medical necessity. That is the key to the business: it is less like a hospital and more like a premium service you decide to buy. People choose EuroEyes because the surgery is fast, the technology is modern, and the brand has built a reputation over many thousands of operations. The founder, Dr. Jørn Slot Jørgensen, is an eye surgeon himself, and the company grew from a single practice into a network of clinics listed on the Hong Kong Stock Exchange. That listing is a bit unusual for a German healthcare company, but it gives it access to investors in Asia, where its China clinics are a big part of the growth story. China matters because a huge number of people there have poor eyesight and a growing middle class willing to pay for a fix.


The business makes money per procedure, so its fortunes rise and fall with how many people book surgery and how much they pay. That leaves it exposed to economic downturns, when people postpone optional spending, and to competition from other clinics and hospitals offering similar treatments. Still, the model is straightforward and cash-generative: patients pay upfront, the clinics use their equipment heavily, and profits can be reinvested into new locations and better technology.

Saved answer · last researched 16 Nov 2026